ArticleBMC cancer2024

Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma.

Dong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.